The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PACE-A: An international phase 3 randomised controlled trial (RCT) comparing stereotactic body radiotherapy (SBRT) to surgery for localised prostate cancer (LPCa)—Primary endpoint analysis.
 
Nicholas John Van As
Honoraria - Accuray
Consulting or Advisory Role - Accuray; Sanofi
Research Funding - Accuray (Inst); Varian Biopharma (Inst)
 
Alison Tree
Leadership - Elekta MRL Consortium (Inst)
Honoraria - Accuray; Elekta; Janssen (Inst)
Research Funding - Accuray (Inst); Elekta (Inst)
Travel, Accommodations, Expenses - Elekta MRL Consortium
 
Peter James Ostler
No Relationships to Disclose
 
Hans van der Voet
No Relationships to Disclose
 
Daniel Ford
Employment - GenesisCare
Honoraria - Janssen; Pfizer
Travel, Accommodations, Expenses - GenesisCare
 
Shaun Tolan
No Relationships to Disclose
 
Paula Wells
Honoraria - Astellas Pharma
 
Rana Mahmood
No Relationships to Disclose
 
Mathias Winkler
No Relationships to Disclose
 
Andrew Chan
No Relationships to Disclose
 
Alan Thompson
No Relationships to Disclose
 
Christopher Ogden
No Relationships to Disclose
 
Stephanie Brown
Research Funding - Accuray (Inst); Varian Biopharma (Inst)
 
Julia Pugh
Research Funding - Accuray (Inst); Varian Biopharma (Inst)
 
Stephanie M. Burnett
Research Funding - Accuray (Inst); Varian Biopharma (Inst)
 
Clare Griffin
Research Funding - Accuray (Inst); Varian Biopharma (Inst)
 
Jaymini Patel
Research Funding - Accuray (Inst); Varian Biopharma (Inst)
 
Olivia Naismith
No Relationships to Disclose
 
Emma Hall
Research Funding - Accuray (Inst); AstraZeneca (Inst); Aventis Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst); Merck Sharpe & Dohme (Inst); Roche (Inst); Varian Medical Systems (Inst)